192 related articles for article (PubMed ID: 26343708)
1. Development of Biodegradable Polycation-Based Inhalable Dry Gene Powders by Spray Freeze Drying.
Okuda T; Suzuki Y; Kobayashi Y; Ishii T; Uchida S; Itaka K; Kataoka K; Okamoto H
Pharmaceutics; 2015 Aug; 7(3):233-54. PubMed ID: 26343708
[TBL] [Abstract][Full Text] [Related]
2. Development of New Formulation Dry Powder for Pulmonary Delivery Using Amino Acids to Improve Stability.
Suzuki Y; Okuda T; Okamoto H
Biol Pharm Bull; 2016; 39(3):394-400. PubMed ID: 26725531
[TBL] [Abstract][Full Text] [Related]
3. Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation.
Mohri K; Okuda T; Mori A; Danjo K; Okamoto H
J Control Release; 2010 Jun; 144(2):221-6. PubMed ID: 20184930
[TBL] [Abstract][Full Text] [Related]
4. Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity.
Okuda T; Morishita M; Mizutani K; Shibayama A; Okazaki M; Okamoto H
J Control Release; 2018 Jun; 279():99-113. PubMed ID: 29627404
[TBL] [Abstract][Full Text] [Related]
5. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
[TBL] [Abstract][Full Text] [Related]
6. Spray freeze drying for dry powder inhalation of nanoparticles.
Ali ME; Lamprecht A
Eur J Pharm Biopharm; 2014 Aug; 87(3):510-7. PubMed ID: 24657824
[TBL] [Abstract][Full Text] [Related]
7. Application of spray freeze drying to theophylline-oxalic acid cocrystal engineering for inhaled dry powder technology.
Tanaka R; Hattori Y; Otsuka M; Ashizawa K
Drug Dev Ind Pharm; 2020 Feb; 46(2):179-187. PubMed ID: 31937148
[TBL] [Abstract][Full Text] [Related]
8. Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.
Otake H; Okuda T; Hira D; Kojima H; Shimada Y; Okamoto H
Pharm Res; 2016 Apr; 33(4):922-31. PubMed ID: 26643921
[TBL] [Abstract][Full Text] [Related]
9. [Development of Inhalable Dry Powder Formulations Loaded with Nanoparticles Maintaining Their Original Physical Properties and Functions].
Okuda T
Yakugaku Zasshi; 2017; 137(11):1339-1348. PubMed ID: 29093369
[TBL] [Abstract][Full Text] [Related]
10. Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids.
Liang W; Kwok PC; Chow MY; Tang P; Mason AJ; Chan HK; Lam JK
Eur J Pharm Biopharm; 2014 Jan; 86(1):64-73. PubMed ID: 23702276
[TBL] [Abstract][Full Text] [Related]
11. Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery.
Farinha S; Sá JV; Lino PR; Galésio M; Pires J; Rodrigues MÂ; Henriques J
Pharm Res; 2023 May; 40(5):1115-1140. PubMed ID: 36456666
[TBL] [Abstract][Full Text] [Related]
12. Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections.
Leung SS; Parumasivam T; Gao FG; Carrigy NB; Vehring R; Finlay WH; Morales S; Britton WJ; Kutter E; Chan HK
Pharm Res; 2016 Jun; 33(6):1486-96. PubMed ID: 26928668
[TBL] [Abstract][Full Text] [Related]
13. [Development of an Inhalation Dry Powder Preparation Method without Heat-drying Process].
Ito T
Yakugaku Zasshi; 2023; 143(4):353-358. PubMed ID: 37005236
[TBL] [Abstract][Full Text] [Related]
14. Development of Spray-Freeze-Dried Powders for Inhalation with High Inhalation Performance and Antihygroscopic Property.
Otake H; Okuda T; Okamoto H
Chem Pharm Bull (Tokyo); 2016; 64(3):239-45. PubMed ID: 26725381
[TBL] [Abstract][Full Text] [Related]
15. Bovine serum albumin as a lyoprotectant for preparation of DNA dry powder formulations using the spray-freeze drying method.
Tsukamoto M; Okuda T; Okamoto H; Higuchi Y; Kawakami S; Yamashita F; Hashida M
Biol Pharm Bull; 2012; 35(7):1178-81. PubMed ID: 22791169
[TBL] [Abstract][Full Text] [Related]
16. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
Lu W; Rades T; Rantanen J; Yang M
Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
[TBL] [Abstract][Full Text] [Related]
17. Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying.
Seville PC; Kellaway IW; Birchall JC
J Gene Med; 2002; 4(4):428-37. PubMed ID: 12124985
[TBL] [Abstract][Full Text] [Related]
18. Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy.
Li HY; Neill H; Innocent R; Seville P; Williamson I; Birchall JC
J Drug Target; 2003 Aug; 11(7):425-32. PubMed ID: 15203931
[TBL] [Abstract][Full Text] [Related]
19. Naked pDNA/hyaluronic acid powder shows excellent long-term storage stability and gene expression in murine lungs.
Ito T; Fukuhara M; Okuda T; Okamoto H
Int J Pharm; 2020 Jan; 574():118880. PubMed ID: 31811928
[TBL] [Abstract][Full Text] [Related]
20. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
Yu H; Teo J; Chew JW; Hadinoto K
Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
